- Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals. 2003. Shepherd, J., Hunninghake, D.B., Barter, P., McKenney, J.M., Hutchinson, H.G. Atherosclerosis. Supplements. (2004)